Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alkermes (ALKS) Cash & Equivalents: 2010-2025

Historic Cash & Equivalents for Alkermes (ALKS) over the last 15 years, with Sep 2025 value amounting to $616.4 million.

  • Alkermes' Cash & Equivalents rose 55.55% to $616.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $616.4 million, marking a year-over-year increase of 55.55%. This contributed to the annual value of $291.1 million for FY2024, which is 36.36% down from last year.
  • According to the latest figures from Q3 2025, Alkermes' Cash & Equivalents is $616.4 million, which was up 18.28% from $521.2 million recorded in Q2 2025.
  • Over the past 5 years, Alkermes' Cash & Equivalents peaked at $665.8 million during Q2 2023, and registered a low of $205.0 million during Q1 2021.
  • Over the past 3 years, Alkermes' median Cash & Equivalents value was $457.5 million (recorded in 2023), while the average stood at $479.4 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first spiked by 161.46% in 2023, then crashed by 38.82% in 2024.
  • Alkermes' Cash & Equivalents (Quarterly) stood at $337.5 million in 2021, then dropped by 13.35% to $292.5 million in 2022, then skyrocketed by 56.41% to $457.5 million in 2023, then crashed by 36.36% to $291.1 million in 2024, then surged by 55.55% to $616.4 million in 2025.
  • Its Cash & Equivalents was $616.4 million in Q3 2025, compared to $521.2 million in Q2 2025 and $399.8 million in Q1 2025.